ADMINISTRATION SITE WARMTH

This adverse event was reported 82 times

ADMINISTRATION SITE WARMTH is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 L-GLUTAMINE 1 0.0028
1 CABOTEGRAVIR SODIUM 4 0.0025
2 QUIZARTINIB 1 0.0014
3 L-LYSINE 1 0.0014
4 TERCONAZOLE 1 0.0012
5 DALBAVANCIN 1 0.0010
6 HUMAN IMMUNOGLOBULIN G 11 0.0005
7 PLECANATIDE 1 0.0005
8 DICLOFENAC EPOLAMINE 2 0.0005
9 DEOXYCHOLIC ACID 1 0.0004
See all drugs enriched for association with ADMINISTRATION SITE WARMTH